Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 21 | 2024 | 420 | 6.920 |
Why?
|
| Zebrafish Proteins | 12 | 2024 | 129 | 4.600 |
Why?
|
| Embryo, Nonmammalian | 11 | 2024 | 145 | 2.420 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2024 | 303 | 2.280 |
Why?
|
| Endocrine Disruptors | 5 | 2022 | 53 | 1.930 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2023 | 3 | 1.590 |
Why?
|
| Receptors, Estrogen | 8 | 2019 | 741 | 1.580 |
Why?
|
| Estradiol | 8 | 2020 | 488 | 1.530 |
Why?
|
| Estrogens | 8 | 2022 | 435 | 1.320 |
Why?
|
| Water Pollutants, Chemical | 3 | 2019 | 40 | 1.160 |
Why?
|
| Green Fluorescent Proteins | 5 | 2016 | 396 | 1.030 |
Why?
|
| Models, Animal | 4 | 2024 | 471 | 0.930 |
Why?
|
| Edema, Cardiac | 1 | 2024 | 3 | 0.910 |
Why?
|
| Receptors, Androgen | 3 | 2024 | 410 | 0.860 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2023 | 381 | 0.830 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 95 | 0.820 |
Why?
|
| Larva | 4 | 2017 | 259 | 0.800 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2022 | 67 | 0.770 |
Why?
|
| Animals, Genetically Modified | 8 | 2022 | 342 | 0.750 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 392 | 0.750 |
Why?
|
| Immunity, Innate | 1 | 2024 | 414 | 0.700 |
Why?
|
| Genes, Reporter | 3 | 2022 | 365 | 0.700 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 91 | 0.690 |
Why?
|
| Animals | 25 | 2024 | 34989 | 0.680 |
Why?
|
| Receptors, Steroid | 1 | 2021 | 175 | 0.670 |
Why?
|
| Animal Fins | 1 | 2019 | 2 | 0.630 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2019 | 6 | 0.630 |
Why?
|
| Endothelial Cells | 1 | 2023 | 530 | 0.620 |
Why?
|
| Cardiotoxicity | 1 | 2019 | 40 | 0.610 |
Why?
|
| Vaccines | 1 | 2024 | 381 | 0.610 |
Why?
|
| Testosterone | 1 | 2024 | 611 | 0.600 |
Why?
|
| Sex Determination Analysis | 1 | 2018 | 16 | 0.590 |
Why?
|
| Sex Differentiation | 1 | 2018 | 20 | 0.560 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2024 | 1019 | 0.560 |
Why?
|
| Skull | 1 | 2019 | 144 | 0.560 |
Why?
|
| Oogenesis | 1 | 2018 | 55 | 0.550 |
Why?
|
| Receptor Cross-Talk | 1 | 2017 | 36 | 0.540 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 254 | 0.530 |
Why?
|
| Testis | 2 | 2018 | 423 | 0.530 |
Why?
|
| Microscopy, Fluorescence | 3 | 2016 | 329 | 0.530 |
Why?
|
| Toxicology | 1 | 2016 | 8 | 0.520 |
Why?
|
| Spermatogenesis | 1 | 2018 | 176 | 0.510 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 196 | 0.500 |
Why?
|
| Ovary | 1 | 2018 | 371 | 0.480 |
Why?
|
| Heart Rate | 1 | 2017 | 573 | 0.450 |
Why?
|
| Molecular Imaging | 1 | 2011 | 63 | 0.340 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 430 | 0.310 |
Why?
|
| Estrogen Antagonists | 3 | 2016 | 97 | 0.310 |
Why?
|
| Signal Transduction | 7 | 2024 | 4725 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1669 | 0.280 |
Why?
|
| Liver | 4 | 2020 | 1815 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 246 | 0.270 |
Why?
|
| Aquaporins | 1 | 2006 | 18 | 0.250 |
Why?
|
| Brain Chemistry | 1 | 2006 | 118 | 0.240 |
Why?
|
| Cell Nucleus | 2 | 2018 | 596 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 1132 | 0.220 |
Why?
|
| Ligands | 2 | 2016 | 493 | 0.210 |
Why?
|
| Androgens | 1 | 2024 | 277 | 0.190 |
Why?
|
| Mutation | 3 | 2024 | 6248 | 0.190 |
Why?
|
| Dimerization | 1 | 2022 | 149 | 0.190 |
Why?
|
| Oocytes | 2 | 2018 | 291 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 2446 | 0.180 |
Why?
|
| Aging | 1 | 2008 | 1261 | 0.170 |
Why?
|
| Mammals | 1 | 2022 | 272 | 0.170 |
Why?
|
| Biliary Tract | 1 | 2020 | 13 | 0.170 |
Why?
|
| Ethinyl Estradiol | 2 | 2017 | 11 | 0.170 |
Why?
|
| Estrogen Receptor beta | 1 | 2020 | 78 | 0.170 |
Why?
|
| Heart | 1 | 2024 | 699 | 0.160 |
Why?
|
| Phenols | 2 | 2017 | 57 | 0.160 |
Why?
|
| Folate Receptor 1 | 1 | 2019 | 30 | 0.160 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 40 | 0.160 |
Why?
|
| Benzhydryl Compounds | 2 | 2017 | 68 | 0.160 |
Why?
|
| Embryonic Development | 2 | 2019 | 221 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2021 | 474 | 0.150 |
Why?
|
| Sex Ratio | 1 | 2018 | 12 | 0.150 |
Why?
|
| Female | 10 | 2020 | 70788 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2011 | 412 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2017 | 11 | 0.140 |
Why?
|
| Time Factors | 3 | 2017 | 6455 | 0.140 |
Why?
|
| Triiodothyronine | 1 | 2017 | 60 | 0.140 |
Why?
|
| Pituitary Gland | 1 | 2017 | 81 | 0.130 |
Why?
|
| Folic Acid | 1 | 2019 | 290 | 0.130 |
Why?
|
| Cyclosporine | 1 | 2017 | 127 | 0.130 |
Why?
|
| Brain | 1 | 2008 | 3197 | 0.130 |
Why?
|
| Response Elements | 1 | 2016 | 98 | 0.120 |
Why?
|
| Fertility | 1 | 2018 | 260 | 0.120 |
Why?
|
| Male | 8 | 2020 | 65054 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 134 | 0.110 |
Why?
|
| Hemangioblasts | 1 | 2014 | 2 | 0.110 |
Why?
|
| Automation | 1 | 2014 | 63 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2023 | 2494 | 0.100 |
Why?
|
| Cell Line | 3 | 2020 | 2730 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2706 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 444 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2011 | 13 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 57 | 0.090 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 17 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 60 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2931 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 554 | 0.080 |
Why?
|
| Humans | 7 | 2024 | 132336 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 990 | 0.080 |
Why?
|
| Uterus | 1 | 2014 | 547 | 0.080 |
Why?
|
| Endocrine System | 1 | 2008 | 18 | 0.070 |
Why?
|
| Neurons | 2 | 2011 | 2016 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1394 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2020 | 241 | 0.070 |
Why?
|
| Morpholinos | 2 | 2020 | 10 | 0.070 |
Why?
|
| Germ Cells | 1 | 2008 | 204 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 1294 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 1125 | 0.060 |
Why?
|
| Cricetulus | 1 | 2006 | 93 | 0.060 |
Why?
|
| CHO Cells | 1 | 2006 | 158 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2006 | 124 | 0.060 |
Why?
|
| Cricetinae | 1 | 2006 | 381 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 358 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2006 | 329 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 543 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 652 | 0.060 |
Why?
|
| Dogs | 1 | 2006 | 655 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2006 | 617 | 0.060 |
Why?
|
| Purkinje Cells | 1 | 2006 | 165 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 761 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 482 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2673 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3780 | 0.040 |
Why?
|
| Hippocampus | 1 | 2006 | 819 | 0.040 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 12 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2019 | 35 | 0.040 |
Why?
|
| Oxazines | 1 | 2019 | 26 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3619 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 399 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1331 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 25 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 52 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2019 | 41 | 0.040 |
Why?
|
| Pyridones | 1 | 2019 | 130 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 249 | 0.040 |
Why?
|
| Piperazines | 1 | 2019 | 254 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 447 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 447 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 482 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 359 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 732 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1353 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 2014 | 2 | 0.030 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Ephrin-B2 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2014 | 37 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 62 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1564 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 38 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2013 | 54 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 156 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1975 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 470 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 436 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2014 | 213 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 899 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2512 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1292 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 615 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 439 | 0.020 |
Why?
|
| Mice | 1 | 2006 | 18571 | 0.020 |
Why?
|
| HIV Infections | 1 | 2019 | 2063 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7567 | 0.020 |
Why?
|